Gilenya wins US FDA approval
Novartis AG won U.S. regulatory approval to sell Gilenya, beating Merck KGaA in a very race to market place the first pill to slow several sclerosis.
The Foods and Drug Administration cleared the medication for use against relapsing kinds of the neurological disease, the Basel, Switzerland-based company stated these days in a assertion. Novartis changed the spelling with the pill’s identify to Gilenya from Gilenia throughout the FDA’s review.
read more detail at:
Incoming search terms :
· gilenia · gilenya · gilenia novartis · gilenia name chanage · blog Gilenya September · gilenya gilenia novartis · gilenya gilenia change name · Gilenya Gilenia · gilenia vs gilenya · gilenia gilenya ·
